Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Radiation Injuries 1Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2trametinib 1tozuleristide 1tovorafenib 1tocilizumab 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vemurafenib 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Qsymia 1Phentermine 1Oxytocin 1Methionine 1Memantine 1Medication Errors 1Ginkgo biloba extract 1Exenatide 1Donepezil 1Contrast Media 1CKD732 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Craniopharyngioma × Ginkgo biloba extract × Clear all
NCT00070161 2021-09-09

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Wake Forest University Health Sciences

Phase 2 Completed
68 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Radiation Injuries, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡